Refine by
Autosampling Articles & Analysis
17 news found
Advanced Instruments, the leading supplier in osmolality testing, announces the newest update to its clinical line of freezing point osmometers. The OsmoPRO® MAX is designed for clinical laboratories of all sizes seeking enhanced productivity through automation. The instrument uses innovative flow-through technology to eliminate manual pipetting and reduce the use of consumables, allowing ...
Why should payers care about clinical laboratory testing? Clinical laboratory testing plays an essential role in the delivery of health care. From early detection and diagnosis of disease to individualized treatment plans based on a person’s unique biology, medical care depends on accurate and timely health data. Seventy percent of medical decisions depend on lab test results, so making ...
The Accelerate Arc System cuts hours of wait time and numerous manual steps to deliver Identification (ID) results Unlocks rapid microbial ID from positive blood cultures for the large installed base of MALDI system users Accelerate Diagnostics, Inc. (NASDAQ: AXDX) an in-vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis, ...
As a leading company for AI-Driven IVD equipments, Reetoo will be attending AACC (American Association for Clinical Chemistry), which will take place at the McCormick Place Convention Center in Chicago from July 26 to 28. We will bring our latest products to the exhibition as below, and look forward to meeting you at our booth #4060. RT-F600: Automatic Vaginal Secretion Analyzer ...
Designed for labs with MALDI platforms, the Accelerate Arc Module and BC kit is a novel application of inline centrifugation and automated sample prep techniques, which together with the blood culture (BC) kit, provides a suspension of cleaned microbial cells for direct transfer to a MALDI spotting plate. Accelerate Arc system now available as a registered IVD Today we announced the completed ...
Babson Diagnostics, a science-first, health care technology company, and BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the expansion of a strategic partnership to move blood sample collection into new care settings, including enabling patients to collect blood samples at home for diagnostic testing. Since 2019, the two companies ...
Today we announced the release of new performance data across two studies for the Accelerate Arc module and BC kit at the 32nd European Congress for Clinical Microbiology and Infectious Diseases (ECCMID) located in Lisbon, Portugal 23-26 April 2022. Two posters featuring performance of the Accelerate Arc System will be presented on Monday April 25th, 12:00- 13:00 hr, Pavilion 3 of the Feira ...
Since the emergence of SARS-CoV-2, public health laboratories and researchers have been developing surveillance methods using wastewater to control the spread of COVID-19. The effort has helped identify asymptomatic carriers on college campuses to monitor regional spread among communities and capture emerging mutations ahead of potential future outbreaks. To support these efforts, Thermo Fisher ...
In Patients Who Receive Ineffective Empirical Antibiotics for Blood Stream Infections (BSI), Use of AXDX Was Associated With Reduction in 30-Day Mortality Interim Data From Multicenter Study Highlight the Real-World Clinical Utility of Fast Phenotypic Antimicrobial Susceptibility Testing for BSI Across Diverse Healthcare Settings and Patient Populations Accelerate Diagnostics, Inc. ...
Study Published in British Journal of Cancer Shows High Sensitivity and Specificity of Tethis’ Liquid Biopsy Platform in Early Stage Breast Cancer and the Identification of Circulating Tumor Cells Clusters for the First Time in Non-Metastatic Patients Tethis S.p.A announced the publication of a pilot study in early breast cancer showing the analytical performance of the novel SBS® ...
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) today announced that the Company has received U.S. Food and Drug Administration (FDA) clearance for a new suite of product enhancements to the Accelerate Pheno® system, which improve performance and expand the system's antimicrobial susceptibility testing (AST) menu for bloodstream infections. The new product release, formally classified as FDA ...
Thermo Fisher Scientific, the world leader in serving science, today announced new collaborations of the Thermo Fisher Precision Medicine Science Center (PMSC) with AstraZeneca and the University of Nebraska Medical Center as part of its ongoing development of innovative solutions for unmet needs in clinical biomarker discovery. The new alliances strengthen the PMSC's mission of creating ...
Grifols has adopted a number of measures since the onset of the pandemic in order to respond to the needs of its stakeholders. The company continually monitors the progression of COVID-19, analyzing and evaluating its potential impact on its workforce and operations to guarantee minimal delays or interruptions in our operations as Grifols’ products and services are essential for patients ...
ELITechGroup Molecular Diagnostics announce today the CE-IVD marking of the CRE ELITe MGB kit, a high-performance, qualitative, multiplex assay for the rapid detection of the Carbapenem Resistance genes of Enterobacteriaceae. In combination with the ELITe InGenius™, the ELITech Group’s fully automated sample-to-result system, the assay is intended to detect 150 variants belonging to ...
ATTSU has started up a 2,000 kg/h ATTSU boiler working at 8 bars at Grifols pharmaceutical company new venue at Parets del Vallès Industrial Park (Barcelona) in which will achieve two-fold fractioning capacity in plasma in Spain up to 4.2 million liter/year. Grifols, leading pharmaceutical company at international level opts for an ATTSU Boiler, offering a better high technology solution ...
Mountford and her team are using Agilent's 400-MR NMR Spectrometer, the 7510-AS Autosampler, and NMR probes and software at a new state-of-the-art NMR imaging center at Hunter Medical Research Institute. ...
Portable laboratories the size of your palm, capable of analysing food for diseases such as salmonella, no longer belong in the realms of science fiction. A team of European researchers are on the fast track to producing just such a lab. OptoLabCard, a project funded by the EU to the tune of over EUR 3 million, offers to not only protect the health and well-being of millions of Europeans but also ...